Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Recent advances in mRNA cancer vaccines: meeting challenges and embracing opportunities
Bolin Wang, Jinli Pei, Shengnan Xu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 61

Showing 1-25 of 61 citing articles:

Signaling pathways involved in colorectal cancer: pathogenesis and targeted therapy
Qing Li, Shan Geng, Hao Luo, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 39
Current and future immunotherapeutic approaches in pancreatic cancer treatment
Pooya Farhangnia, Hossein Khorramdelazad, Hamid Nickho, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 33
Present and future of cancer nano-immunotherapy: opportunities, obstacles and challenges
Man Wang, Fei Yu, Yuan Zhang
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 5
Safety and immunogenicity of an optimized self-replicating RNA platform for low dose or single dose vaccine applications: a randomized, open label Phase I study in healthy volunteers
Christian J. Maine, Shigeki J. Miyake-Stoner, Darina Spasova, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 3
DNA vaccines as promising immuno-therapeutics against cancer: a new insight
Alireza Shariati, Arya Khezrpour, Fatemeh Sadat Shariati, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access | Times Cited: 2
Transforming Medicine: Cutting-Edge Applications of Nanoscale Materials in Drug Delivery
Rumiana Koynova, Kevin J. Hughes, Magesh Ganesan, et al.
ACS Nano (2025)
Open Access | Times Cited: 2
Advances in mRNA-Based Cancer Vaccines
Ling Ni
Vaccines (2023) Vol. 11, Iss. 10, pp. 1599-1599
Open Access | Times Cited: 22
Revolutionizing Cancer Treatment: Recent Advances in Immunotherapy
Rose Ghemrawi, Lama Abuamer, Sedra Kremesh, et al.
Biomedicines (2024) Vol. 12, Iss. 9, pp. 2158-2158
Open Access | Times Cited: 10
Research progress on the quality control of mRNA vaccines
Chaoying Hu, Yu Bai, Jianyang Liu, et al.
Expert Review of Vaccines (2024) Vol. 23, Iss. 1, pp. 570-583
Open Access | Times Cited: 9
mRNA vaccines in the context of cancer treatment: from concept to application
Qiang Fu, Xiaoming Zhao, Jinxia Hu, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access | Times Cited: 1
Exploring the immuno-nano nexus: A paradigm shift in tumor vaccines
Yuanyuan Li, Yuxing Xu, Wenwen Su, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 184, pp. 117897-117897
Closed Access | Times Cited: 1
mRNA vaccine platforms: linking infectious disease prevention and cancer immunotherapy
Dariush Haghmorad, Majid Eslami, Niloufar Orooji, et al.
Frontiers in Bioengineering and Biotechnology (2025) Vol. 13
Open Access | Times Cited: 1
Recent Findings on Therapeutic Cancer Vaccines: An Updated Review
Sara Sheikhlary, David Humberto Lopez, Sophia Moghimi, et al.
Biomolecules (2024) Vol. 14, Iss. 4, pp. 503-503
Open Access | Times Cited: 7
mRNA vaccines: a new era in vaccine development
Shubhra Chandra, Jennifer C Wilson, David M. Good, et al.
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (2024) Vol. 32, Iss. 10, pp. 1543-1564
Open Access | Times Cited: 7
Lung Cancer Research and Treatment: Global Perspectives and Strategic Calls to Action
May-Lucie Meyer, S. Peters, Tony Mok, et al.
Annals of Oncology (2024)
Closed Access | Times Cited: 6
Cancer vaccines: Target antigens, vaccine platforms and preclinical models
Francesca Ruzzi, Federica Riccardo, Laura Conti, et al.
Molecular Aspects of Medicine (2024) Vol. 101, pp. 101324-101324
Open Access | Times Cited: 6
Enhancing Vaccine Efficacy and Stability: A Review of the Utilization of Nanoparticles in mRNA Vaccines
Nargish Parvin, Sang Woo Joo, Tapas Kumar Mandal
Biomolecules (2024) Vol. 14, Iss. 8, pp. 1036-1036
Open Access | Times Cited: 5
Neoantigen-based mRNA vaccine exhibits superior anti-tumor activity compared to synthetic long peptides in an in vivo lung carcinoma model
Cao Minh Nguyen, Trung Vu, Minh Nguyen Nguyen, et al.
Cancer Immunology Immunotherapy (2025) Vol. 74, Iss. 4
Open Access
Personalized mRNA vaccines in glioblastoma therapy: from rational design to clinical trials
Iman Karimi-Sani, Zahra Molavi, Samaneh Naderi, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4
Cancer theragnostics: closing the loop for advanced personalized cancer treatment through the platform integration of therapeutics and diagnostics
Olga V. Sergeeva, Liang Luo, Anthony Guiseppi‐Elie
Frontiers in Bioengineering and Biotechnology (2025) Vol. 12
Open Access
mRNA lipid nanoparticle-incorporated nanofiber-hydrogel composite generates a local immunostimulatory niche for cancer immunotherapy
Yining Zhu, Zhi‐Cheng Yao, S.-H. Li, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
Breaking barriers: Smart vaccine platforms for cancer immunomodulation
Mohammad Mahmoudi Gomari, Taha Ghantabpour, Nima Pourgholamamiji, et al.
Cancer Communications (2025)
Open Access
Nanoparticles for mRNA-based cancer immunotherapy
Rakesh Pahwa, Gulshan Sharma, Rohil Panwar, et al.
Advances in immunology (2025)
Closed Access
Model‐Informed Drug Development Applications and Opportunities in mRNA‐LNP Therapeutics
Jiawei Zhou, Rohit Rao, Mark Shapiro, et al.
Clinical Pharmacology & Therapeutics (2025)
Open Access
Identification of new immune target and signaling for cancer immunotherapy
S. P. Narote, Sharav Desai, Vipul P. Patel, et al.
Cancer Genetics (2025)
Closed Access
Page 1 - Next Page

Scroll to top